Why is marketing approval for the first retinal gene therapy treatment for patients with blinding retinal degenerations so significant? Is there an exciting future for applying stem cell therapy to treating retinal disorders and what are the scientific and ethical challenges in the use of stem cells?
How have researchers from the fields of ophthalmology, vision science, biophysics, neuroscience, neurosurgery, engineering and material sciences come together to restore vision in the blind using implants for electric or optic stimulation of the visual system? How will augmented reality and virtual reality liberate sight-impaired people in an exciting new age of accessibility?
At Retina 2018 New Zealand, some of the world’s foremost retinal scientists and clinicians will offer patients and their families, clinicians, rehabilitation professionals, students and anyone with an interest in retinal disorders with the answers. The congress will be a unique interactive learning and networking opportunity that includes short scientific presentations, expert panels, treatment approach plenaries and social events.
The speaker biographies are available here: http://retina2018newzealand.com/speakers/
Our programme page is at http://retina2018newzealand.com/programme/, and an overview of the programme is attached to this email.
Click on the following link for registration prices, and to register: http://retina2018newzealand.com/registration/
Save the Date
10 – 11 February 2018
Owen G Glenn Building, University of Auckland, Grafton Road, Auckland.
February is a busy time in Auckland and accommodation is likely to sell-out quickly, so we recommend that you book yours soon. Please see the accommodation listings on our website for a range of options, at the following link: http://retina2018newzealand.com/accommodation/
The Conference Website: http://retina2018newzealand.com/
Kate Howard, email: firstname.lastname@example.org